INHALATION OF AZTREONAM LYSINE FOR THE TREATMENT OF VIOLATIONS DECREASING THE QUALITY OF LIFE CAUSED BY HEALTH IN LUNG DISEASES

摘要

The use of an inhaled aerosol to aztreon lysine in the manufacture of a medicament intended for the treatment of symptoms of lung disease that reduce the quality of life due to health (HRQOL) is proposed. The use according to the invention is suitable for continuous long-term treatment of symptoms that reduce the "quality of life due to health condition" (HRQOL).